Last Update

2016-07-28T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Elaine Mardis?

Dr. Elaine R. Mardis

Direct Phone: (314) ***-****       

Email: e***@***.edu

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Genome Sequencing Center

4444 Forest Park Boulevard

St. Louis, Missouri 63108

United States

Company Description

The Genome Partnership has been proudly organizing The Advances in Genome Biology and Technology (AGBT) General Meeting for the past 17 years. In September of 2016 we are launching our inaugural AGBT Precision Health Meeting. The Genome Partnership is a n ... more

Find other employees at this company (43)

Background Information

Affiliations

Board Member
American Association for Cancer Research Inc

Founder
Institute for Genomic Medicine at Nationwide Children's Hospital

Scientific Advisor
Orion Genomics LLC

Advisory Board Member
DNA Sequencing Inc

Advisory Board Member
DNA Sequencing Inc

Scientific Advisory Board Member
Ingenuity Systems Inc

Board Member
Applied Biosystems Inc.

Member
American Society of Human Genetics

Editorial Board Member of Molecular Cancer Research
Disease Models

Education

B.S.

Zoology

Oklahoma University

B.S. degree

zoology

University of Oklahoma

Ph.D.

National Human Genome Research Institute

Ph.D.

The Genome Institute of Washington University

Ph.D.

Washington University

Ph.D.

Washington University School of Medicine

Ph.D.

Biochemistry and Chemistry

University of Oklahoma

Ph.D.

Chemistry and Biochemistry

Oklahoma University

PhD

Scripps Translational Science Institute

PhD

The Genome Institute at Washington University

Web References (197 Total References)


Genomics and Big Data Series: ...

mountsinai.site-ym.com [cached]

Genomics and Big Data Series: Elaine R. Mardis The Mount Sinai Alumni Association

...
Genomics and Big Data Series: Elaine R. Mardis
...
Genomics and Big Data Series: Elaine R. Mardis
In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She now serves as Co-director of The Genome Institute. Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making.
...
Elaine R. Mardis, PhD
Elaine R. Mardis, PhD
...
Elaine R. Mardis, PhD, graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.
In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She now serves as Co-director of The Genome Institute.
Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting.
Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Disease Models and Mechanisms and Annals of Oncology, and acts as a reviewer for Nature, the New England Journal of Medicine, Cell and Genome Research. She is the Editor-in-Chief of Molecular Case Studies. In 2014, Dr. Mardis was named as the Robert E. and Louise F. Dunn Distinguished Professor of Medicine.
...
Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011. Discover Magazine featured her work in cancer genomics as one of their top 100 science stories in 2013.


Others have also noted the importance ...

www.paradigmdx.com [cached]

Others have also noted the importance of sequencing RNA to confirm DNA sequencing results, including Elaine Mardis, co-director of the Genome Institute at Washington University, who in 2011 said that about only 40 percent of mutations in a patient's genome is actually expressed, and added that in looking for target mutations for a drug, targeting mutations in genes that aren't even expressed is probably a fruitless exercise.


Elaine ...

www.eortc.org [cached]

Elaine Mardis

Washington University School of Medicine (Saint Louis, Missouri, USA)
...
Elaine Mardis earned her B.S. in Zoology and a Ph.D. in Chemistry and Biochemistry at Oklahoma University. Following graduation, Dr. Mardis was a senior research at BioRad Laboratories in Hercules, CA. In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. She serves as Co-director of The Genome Institute. Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries in cancer into the clinical setting. Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Disease Models and Mechanisms and Annals of Oncology. She is the Editor-in-Chief of Molecular Case Studies. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumnus of the University of Oklahoma College of Arts and Sciences for 2011. Discover Magazine featured her work in cancer genomics as one of their top 100 science stories in 2013.


Elaine Mardis, Ph.D., ...

www.agbt.org [cached]

Elaine Mardis, Ph.D., graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.

In 1993, Dr. Mardis joined the faculty at Washington University School of Medicine. Recruited for her expertise in DNA sequencing and automation technology, she served as Director of Technology Development at the (then) Washington University Genome Sequencing Center, helping create methods and automation pipelines for sequencing the Human Genome. She has served as Co-director of the McDonnell Genome Institute since 2002. In 2014, Dr. Mardis was named the Robert E. and Louise F. Dunn Distinguished Professor of Medicine.
...
Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She co-led the teams that first used next-generation sequencing to characterize the whole genome of an AML patient (Nature 2008), first sequenced and compared a primary tumor to its metastasis and xenograft, and first reported whole genome sequencing of samples from a breast cancer clinical trial. Beyond cancer genomics discoveries, Dr. Mardis is leading efforts to facilitate the translation of basic science discoveries about human genetic diseases into the clinical setting, especially focused on the use of next-generation sequencing. Her translational research efforts aim to devise NGS-based diagnostics, decision-support tools and databases, and the use of genomics to design personalized cancer vaccines.
Dr. Mardis was elected to the AACR Board of Directors in 2015. She serves as an associate editor of Molecular Cancer Research, Disease Models and Mechanisms and Annals of Oncology, and acts as a reviewer for Nature, the New England Journal, Cell and Science. She is the Editor-in-Chief of Molecular Case Studies. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics, and is a member of the Supervisory Board of Qiagen N.V. Dr. Mardis received the 2010 Scripps Translational Research award for her work on cancer genomics, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences in 2011. Discover Magazine featured her work in cancer genomics as one of their top 100 science stories of 2013. In 2014 and 2015, she was one of the most highly cited researchers in the world, according to Thompson-Reuters. She will receive the Morton K. Schwartz award from the American Association of Clinical Chemistry for Significant Contributions in Cancer Research Diagnostics in 2016.


This is particularly important because ...

www.rapidscience.org [cached]

This is particularly important because journals are often hesitant to publish results from a single individual, notes Elaine Mardis, co-director of the Genome Institute at Washington University in St Louis, Missouri. Mardis has advocated for establishing an online journal that would permit quick publication of n-of-1 results, as a way to rapidly release information and give researchers incentive to study patients who seem to be outliers."

Similar Profiles

Other People with this Name

Other people with the name Mardis

Margaret Mardis
Steve Holt

Detra Mardis
Eaton Corporation

Nicole Mardis
Canadian Institutes of Health Research

Mac Mardis
Kent Construction Inc

Laurie Mardis
BTC Capital Management

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory